NasdaqCM - Nasdaq Real Time Price • USD
Eyenovia, Inc. (EYEN)
At close: May 31 at 4:00 PM EDT
After hours: May 31 at 6:05 PM EDT
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
-
-
-
-
-
-
Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension
Clobetasol propionate ophthalmic suspension obtained US FDA approval in March 2024.
Pharmaceutical Technology • 21 days ago -
-
-
-
-
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents • 2 months ago -
-
Q4 2023 Eyenovia Inc Earnings Call
Q4 2023 Eyenovia Inc Earnings Call
Thomson Reuters StreetEvents • 2 months ago -
-
-
-
-
-
-
Performance Overview
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | EYEN | S&P 500 |
---|---|---|
YTD | -61.15% | +10.64% |
1-Year | -71.90% | +25.49% |
3-Year | -83.10% | +25.53% |